Jade Biosciences JBIO
NASDAQ JBIO
$14.12 +0.35 (+2.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jade Biosciences (JBIO) Change in Accured Expenses (2020 - 2026)

Updated

Jade Biosciences' Change in Accured Expenses was $84,000 in Q2 2026, down 98.3% from $4.81 million a year earlier and down 98.5% from the prior quarter.

Analysis

Jade Biosciences (JBIO) Change in Accured Expenses (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Jade Biosciences' Change in Accured Expenses was $6.94 million through Jun 30, 2026, down 38.3% year-over-year; for FY2025, it came in at $3.94 million.

  • Change in Accured Expenses shows a five-year compound annual growth rate of 30.6% (FY2020 to FY2025).
  • In earlier years, Change in Accured Expenses was -$9.91 million in FY2024, $10 million in FY2023 (+172.3%), $3.67 million in FY2022 and -$6,000 in FY2021.
  • Quarterly Change in Accured Expenses has moved between -$3.5 million (Q4 2025) and $8.13 million (Q4 2024) over five years.
  • Compared with a year earlier, Change in Accured Expenses was higher in two of the last four quarters, with growth averaging 156.2%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q2 2025 (growth of 715.3%); the worst was Q2 2026 (a decline of 98.3%).
  • Per Business Quant data, JBIO's Change in Accured Expenses in the three quarters before Q2 2026 was $5.77 million (Q1 2026), -$3.5 million (Q4 2025) and $4.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Jade Biosciences 897.41 Mn 897.41 Mn - 84,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 84,000.00
Mar 31, 2026 5.77 Mn
Dec 31, 2025 -3.50 Mn
Sep 30, 2025 4.58 Mn
Jun 30, 2025 4.81 Mn
Mar 31, 2025 -1.95 Mn
Dec 31, 2024 -5.76 Mn
Sep 30, 2024 244,000.00
Jun 30, 2024 606,000.00
Mar 31, 2024 -3.06 Mn
Dec 31, 2023 4.05 Mn
Sep 30, 2023 3.39 Mn
Jun 30, 2023 1.84 Mn
Mar 31, 2023 716,000.00
Dec 31, 2022 2.04 Mn
Sep 30, 2022 1.44 Mn
Jun 30, 2022 -306,000.00
Mar 31, 2022 497,000.00
Dec 31, 2021 27,000.00
Sep 30, 2021 -28,000.00
API Access

Jade Biosciences Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=JBIO&period=max&api_key=YOUR_API_KEY